Our member stories
Discover why your peers are part of
this innovative targeted therapies network
“While of course we need to be sensitive to IP, it’s just not efficient for individual companies to continue to work in isolation, so it’s vital we pool experiences and I’m excited about where this might lead.”
Steve Kelsey, President – R&D, Revolution
“This is such a great idea. Some will inevitably be defined by what they can’t share but there are definitely others out there who aren’t and I think this is a necessary conversation which has my support.”
Greg Friberg, Vice President Medical Affairs, Amgen
“This network is so valuable because it helps us understand the challenges our peers are facing and get ideas as to how they are planning on overcoming them so that together we all can work towards getting better treatments to cancer patients, faster.”
Aparajita Chourasia, Vice President – Biology, Biotheryx
“The value we see is in the focused exchange of novel ideas involving biologists, clinicians, and scientists in the industry, bringing together analysis from different perspectives which helps us walk away with a clearer picture we can bring to our own work.”
Nahuel Villegas, CSO, Vivan Therapeutics
“Through the exchange of novel ideas that could more quickly advance clinical programs around cancers that are driven by RAS activation, this network sets out to help both the scientific community and more importantly the patient population move forward faster”
Steven Frutchman, President & CEO, Onconova
Accelerate your RAS-Targeted
Therapies success
Be inspired by forward-thinking leaders. Grow beyond your perceived limits.
Connect with members. Redefine and realize your business goals
with Searchlight by Hanson Wade.